Proposed criteria for response assessment in patients treated in clinical trials for myeloproliferative neoplasms in blast phase (MPN-BP): Formal recommendations from the post-myeloproliferative neoplasm acute myeloid leukemia consortium-Reference-Cited by-同舟云学术

Proposed criteria for response assessment in patients treated in clinical trials for myeloproliferative neoplasms in blast phase (MPN-BP): Formal recommendations from the post-myeloproliferative neoplasm acute myeloid leukemia consortium

Published:2012-12 Issue:12 Volume:36 Page:1500-1504
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Mascarenhas John,Heaney Mark L.,Najfeld Vesna,Hexner Elizabeth,Abdel-Wahab Omar,Rampal Raajit,Ravandi Farhad,Petersen Bruce,Roboz Gail,Feldman Eric,Podoltsev Nikolai,Douer Dan,Levine Ross,Tallman Martin,Hoffman Ronald

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference39 articles.

1. WHO classification of tumours of haematopoietic and lymphoid tissues;Swerdlow,2008

2. Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT)

3. Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients;Gangat;Leukemia,2007

4. The leukemia controversy in myeloproliferative disorders: is it a natural progression of disease, a secondary sequela of therapy, or a combination of both?;Barbui;Semin Hematol,2004

5. Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases;Mesa;Blood,2005

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The utility of next generation sequencing-based minimal residual disease monitoring in a post-myeloproliferative neoplasm acute myeloid leukemia patient: a case report;Leukemia & Lymphoma;2024-07-29

2. Национальные клинические рекомендации по диагностике и лечению Ph-негативных миелопролиферативных новообразований (истинной полицитемии, эссенциальной тромбоцитемии, первичного миелофиброза) (редакция 2024 г.);Clinical Oncohematology;2024-07-01

3. Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era;Blood Advances;2024-06-28

4. Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN;Blood Advances;2024-03-04

5. SOHO State of the Art Updates and Next Questions | Accelerated Phase of MPN: What It Is and What to Do About It;Clinical Lymphoma Myeloma and Leukemia;2023-05